Search Results - "Ozkaynak, Mehmet"

Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipients by Militano, Olga, Ozkaynak, Mehmet F., Mehta, Brinda, deVen, Carmella, Hamby, Carl, Cairo, Mitchell S.

“…Background The optimal dose and schedule of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant recipients remains to be determined. We…”
Get full text

A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders by Bhunia, Nabanita, Abu‐Arja, Rolla, Stanek, Joseph R., Mehyar, Lubna S., Shaw, Peter J., Kang, Hyoung Jin, Stein, Jerry, O'Brien, Tracey A., Roberts, Catherine H., Lee, Anselm Chi‐wai, Loeb, David M., Ozkaynak, Mehmet F., Dalal, Jignesh D., Strahlendorf, Caron, Goyal, Rakesh K., Shenoy, Shalini S., Rangarajan, Hemalatha G.

“…Background Pleraxifor for peripheral blood stem cell (PBSC) mobilization in children with malignancies is often given following failure of standard…”
Get full text

Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts by Chu, Yaya, Nayyar, Gaurav, Tian, Meijuan, Lee, Dean A, Ozkaynak, Mehmet F, Ayala-Cuesta, Jessica, Klose, Kayleigh, Foley, Keira, Mendelowitz, Alyssa S, Luo, Wen, Liao, Yanling, Ayello, Janet, Behbehani, Gregory K, Riddell, Stanley, Cripe, Tim, Cairo, Mitchell S

“…The prognosis for children with recurrent and/or refractory neuroblastoma (NB) is dismal. The receptor tyrosine kinase-like orphan receptor 1 (ROR1), which is…”
Get full text

Acquired Thrombotic Thrombocytopenic Purpura in Children: A Single Institution Experience by Jayabose, Somasundaram, Nowicki, Theodore S., Dunbar, Julie, Levendoglu-Tugal, Oya, Ozkaynak, Mehmet F., Sandoval, Claudio

“…Objective To describe the clinical features, treatment and prognosis of acquired thrombotic thrombocytopenic purpura (TTP) in children based on a single…”
Get full text

Favorable outcome of primary CNS anaplastic large cell lymphoma in an immunocompetent patient by Ozkaynak, Mehmet Fevzi

“…A 9-year-old immunocompetent male patient with primary central nervous system anaplastic large cell lymphoma was treated with 5 cycles of intensive…”
Get full text

Cleft palate, bilateral external auditory canal atresia, and other midline defects associated with Diamond-Blackfan anemia: case report by McFarren, Alicia, Jayabose, Somasundaram, Fevzi Ozkaynak, Mehmet, Tugal, Oya, Sandoval, Claudio

“…Diamond-Blackfan anemia (DBA) is associated with congenital anomalies especially of the midline. When present, facial anomalies are reminiscent of…”
Get full text

Gemistocytic Astrocytoma With PNET Tumor Arising Within a Mature Ovarian Teratoma and Seeding Metastasis in a Premenarchal Girl by Fraiser, Candice, MD, Regard, Monique, MD, Ozkaynak, Mehmet Fevzi, MD, Davis, Mary Margaret, MD, MSc

Get full text

RECURRENT IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN by Jayabose, Somasundaram, Levendoglu-Tugal, Oya, Ozkaynak, Mehmet F., Sandoval, Claudio

“…Recurrent immune thrombocytopenic purpura (ITP) is defined as the recurrence of ITP after at least 3 months of remission sustained without treatment. Among 340…”
Get full text

Neuroblastoma masquerading as cervical lymphadenitis by Pepper, Stephanie, Islam, Humayun K, Jayabose, Somasundarm, Ozkaynak, Mehmet F, Tugal, Oya, Sandoval, Claudio

“…Cervical lymphadenitis is a common pediatric finding prompting medical evaluation. The most common etiologies are infectious and reactive. The location of the…”
Get full text

Rituximab Therapy to Prevent Relapse in Chronic Relapsing Thrombotic Thrombocytopenic Purpura (TTP) in a Child by Jayabose, Somasundaram, Dunbar, Julie, Nowicki, Theodore S., Tugal, Oya, Ozkaynak, Mehmet Fevzi, Sandoval, Claudio

“…Our patient first developed thrombotic thrombocytopenic purpura (TTP) at age 10 years with an initial platelet count of 10,000/μL. She achieved remission with…”
Get full text

Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group by Desai, Ami V, Gilman, Andrew L, Ozkaynak, Mehmet Fevzi, Naranjo, Arlene, London, Wendy B, Tenney, Sheena C, Diccianni, Mitchell, Hank, Jacquelyn A, Parisi, Marguerite T, Shulkin, Barry L, Smith, Malcolm, Moscow, Jeffrey A, Shimada, Hiroyuki, Matthay, Katherine K, Cohn, Susan L, Maris, John M, Bagatell, Rochelle, Sondel, Paul M, Park, Julie R, Yu, Alice L

“…Postconsolidation immunotherapy including dinutuximab, granulocyte-macrophage colony-stimulating factor, and interleukin-2 improved outcomes for patients with…”
Get full text

Real-time quantitative PCR: Standardized detection of minimal residual disease in pediatric acute lymphoblastic leukemia by PINE, Sharon R, MOY, Fred H, WIEMELS, Joseph L, GILL, Ramneet K, LEVENDOGLU-TUGAL, Oya, OZKAYNAK, Mehmet F, SANDOVAL, Claudio, JAYABOSE, Somasundaram

Get full text

Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032 by Desai, Ami Vijay, Gilman, Andrew, Ozkaynak, Mehmet Fevzi, Naranjo, Arlene, London, Wendy B, Tenney, Sheena Cretella, Smith, Malcolm, Seibel, Nita, Shimada, Hiroyuki, Matthay, Katherine K., Cohn, Susan Lerner, Maris, John M., Bagatell, Rochelle, Sondel, Paul M., Park, Julie R., Yu, Alice L.

“…Abstract only 10523 Background: Immunotherapy with the anti-GD2 antibody dinutuximab plus sargramostim (GM-CSF), aldesleukin (IL-2) and isotretinoin following…”
Get full text

Laparoscopic Surgery for Acute Appendicitis in Children With Cancer by Singer, Julia, Stringel, Gustavo, Ozkaynak, Mehmet Fevzi, McBride, Whitney, Pandya, Samir, Sandoval, Claudio

“…Abdominal pain during cancer chemotherapy may be caused by medical or surgical conditions. A retrospective review of 5 children with cancer who had…”
Get full text

Impact of KIR/KIR ligand genotype for neuroblastoma patients in a phase III COG immunotherapy trial by Erbe, Amy K, Wang, Wei, Carmichael, Lakeesha, Kim, KyungMann, Mendonca, Eneida A, Song, Yiqiang, Hess, Dustin, London, Wendy B., Hank, Jacquelyn A, Dicciani, Mitchell B, Reisfeld, Ralph A, Gillies, Stephen D, Hogarty, Michael D., Maris, John M., Park, Julie R., Ozkaynak, Mehmet Fevzi, Gilman, Andrew Lee, Yu, Alice L., Sondel, Paul M.

“…Abstract only…”
Get full text

Racial Disparities in Pediatric Immune Thrombocytopenic Purpura by Perkins, Tiffany, Jayabose, Somasundaram, Ozkaynak, Mehmet, Tugal, Oya, Sandoval, Claudio

“…Abstract 4464 Immune thrombocytopenic purpura (ITP) occurs in children with an estimated incidence of 5/100,000; however, it is not known whether racial…”
Get full text

Osteosarcoma Following Growth Hormone Therapy in Recurrent Acute Lymphoblastic Leukemia and Rapadilino Syndrome by Sandoval, Claudio, Dunbar, Julie, Ozkaynak, Mehmet, Jayabose, Somasundaram

Get full text

A comprehensive safety trial of chimeric antibody 14.18 (ch14.18) with GM-CSF, IL-2, and isotretinoin in high-risk neuroblastoma patients following myeloablative therapy: A Children's Oncology Group study by Ozkaynak, Mehmet Fevzi, Gilman, Andrew Lee, Yu, Alice L., London, Wendy B., Sondel, Paul M, Smith, Malcolm A., Seeger, Robert, Reynolds, C. Patrick, Maris, John M., Park, Julie R.

“…Abstract only…”
Get full text

Low day 100 transplant-related mortality (TRM) and relapse rate following clofarabine (CLO) in combination with cytarabine, total body irradiation (TBI), and allogeneic stem cell transplantation (AlloSCT) in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia by Radhakrishnan, Kavita, Ricci, Angela M, Geyer, Mark B, Harrison, Lauren, Duffy, Deirdre, Ozkaynak, Mehmet Fevzi, Satwani, Prakash, Cheerva, Alexandra C, Talano, Julie, Moore, Theodore, Gillio, Alfred P, Wada, Randal K., Baxter-Lowe, Lee Ann, Cairo, Mitchell S.

“…Abstract only 6537 Background: CAYA with ALL or AML in third complete remission (CR3), refractory relapse (RR) or induction failure (IF) have an extremely poor…”
Get full text

Plerixafor Is Highly Effective for the Mobilization of Autologous PBSC for Transplant in Children Failing to Mobilize by Conventional Means: International Experience with 40 Children From 19 Centers by Shenoy, Shalini, Douglas, Kenny W, Korístek, Zdenek, Shaw, Peter J., Stein, Jerry, Mohty, Mohamad, Sevilla, Julián, Ehlert, Karoline, O'Brien, Tracey, Roberts, Catherine, Lee, Anselm, Albert, Michael, Ebinger, Martin, Carter, Tina, Sastry, Jairam, Loeb, David, Ozkaynak, Mehmet F, Dalal, Jignesh, Strahlendorf, Caron, Goyal, Rakesh K, Duarte, Rafael F

“…Abstract 1931 Mobilization of peripheral blood stem cells (PBSC) for autologous transplant in children can be challenging especially in those with prior…”
Get full text